Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC

SIMPLE SUMMARY: Biomarkers to guide clinical decisions and efficacy are limited in advanced non-small cell lung cancer’s anti-PD-1 immune checkpoint inhibitors. We prospectively explored baseline peripheral blood mononuclear cells in order to asses’ immunotherapy predictors in this setting. We inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogado, Jacobo, Pozo, Fernando, Troule, Kevin, Sánchez-Torres, José Miguel, Romero-Laorden, Nuria, Mondejar, Rebeca, Donnay, Olga, Ballesteros, Anabel, Pacheco-Barcia, Vilma, Aspa, Javier, Al-Shahrour, Fátima, Alfranca, Arantzazu, Colomer, Ramon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221141/
https://www.ncbi.nlm.nih.gov/pubmed/35740564
http://dx.doi.org/10.3390/cancers14122898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221141/
https://www.ncbi.nlm.nih.gov/pubmed/35740564
http://dx.doi.org/10.3390/cancers14122898

Ejemplares similares